key: cord-1031739-858d940k authors: Tanikawa, Takashi; Hayashi, Tsuyoshi; Suzuki, Ryuichiro; Kitamura, Masashi; Inoue, Yutaka title: Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection date: 2021-09-16 journal: J Tradit Complement Med DOI: 10.1016/j.jtcme.2021.09.005 sha: f4832e77174add64033735c54857b251919ae98c doc_id: 1031739 cord_uid: 858d940k The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a pandemic and has caused damage to the lives of the people and economy of countries. However, the therapeutic reagents against SARS-CoV-2 remain unclear. The spike (S) protein of SARS-CoV-2 contains a cleavage motif at the S1/S2 boundary, known to be cleaved by furin. As cleavage is essential for S protein activation and viral entry, furin was selected as the target compound. In this study, we examined the inhibitory effects of two lignans (honokiol and magnolol) on furin-like enzymatic activity using a fluorogenic substrate with whole-cell lysates. Of two compounds tested, honokiol partially inhibited furin-like enzymatic activity. We further examined the anti-SARS-CoV-2 activity of honokiol using VeroE6 cell line, which is stably expressing a transmembrane protease serine 2 (TMPRSS2). It was shown that honokiol exhibited remarkable inhibition of SARS-CoV-2 infection. Therefore, honokiol and crude drugs which contain honokiol such as Magnolia species have a potential therapeutic reagents for SARS-CoV-2. The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome 2 coronavirus 2 (SARS-CoV-2) has emerged as a pandemic and has caused damage to the lives of the 3 people and economy of countries. However, the therapeutic reagents against SARS-CoV-2 remain 4 unclear. The spike (S) protein of SARS-CoV-2 contains a cleavage motif at the S1/S2 boundary, 5 known to be cleaved by furin. As cleavage is essential for S protein activation and viral entry, furin 6 was selected as the target compound. In this study, we examined the inhibitory effects of two lignans 7 (honokiol and magnolol) on furin-like enzymatic activity using a fluorogenic substrate with whole-8 cell lysates. Of two compounds tested, honokiol partially inhibited furin-like enzymatic activity. 9 We further examined the anti-SARS-CoV-2 activity of honokiol using VeroE6 cell line, which is 10 stably expressing a transmembrane protease serine 2 (TMPRSS2). It was shown that honokiol 11 exhibited remarkable inhibition of SARS-CoV-2 infection. Therefore, honokiol and crude drugs 12 which contain honokiol such as Magnolia species have a potential therapeutic reagents for SARS-13 CoV-2. 14 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading worldwide, 18 causing over 196 million cases of coronavirus disease 2019 (COVID-19) along with more than 19 4,200,412 deaths (https://covid19.who.int/ accessed July 28, 2021) [1] . The entry of SARS-CoV-2 20 into host cells is mediated by the transmembrane spike glycoprotein (S protein), which forms 21 homotrimers extending from the virus envelope [2-4]. The S protein is processed and activated by 22 cellular proteases, including a transmembrane protease serine 2 (TMPRSS2), cathepsin, and furin 23 [5-7]; it comprises two functional subunits, S1 and S2. The S1 subunit is involved in binding to the 24 host cell receptor, and the S2 subunit participates in the fusion of the virus envelope and host cell 25 membrane [5, 8] . S protein cleavage occurs at the boundary between the S1 and S2 subunits. The 26 S1 subunit of SARS-CoV-2 initiates virus-receptor binding by interacting with the human host cell 27 receptor angiotensin-converting enzyme 2, and the S2 subunit participates in viral fusion with the 28 target cell [6] . The SARS-CoV-2 S protein possesses a multibasic cleavage site for furin at the S1/S2 29 boundary, which contributes to the activation of the fusion machinery of the virus [7, 8] . The sequence at the S1/S2 boundary of the S protein contains a furin cleavage site (RRAR↓S). The 37 multibasic cleavage site in the S protein is essential for SARS-CoV-2 entry into lung cells, and furin 38 inhibitors block S protein processing and SARS-CoV-2 infection [5, 7, 14] . Therefore, furin 39 inhibitors are potential antiviral agents for SARS-CoV-2 infection and pathogenesis [15] . In summary, we showed that honokiol partially inhibited furin-like activity in vitro tests, which can 152 potentially inhibit the analog site in the S protein of SARS-CoV-2. We also showed that SARS-153 CoV-2 infection was suppressed in the presence of honokiol at concentrations that are 154 pharmacologically relevant. Since honokiol is known as an inhibitor of PI3K/Akt signaling in 155 various cell lines, honokiol could inhibit SARS-CoV-2 infection not only by inhibiting furin-like 156 activity but also by blocking PI3K/Akt signaling. 157 Wuhan to World: The COVID-19 Pandemic. Front Cell Infect 160 of SARS-CoV-2 Is Essential for Infection of Human Lung Cells Cell entry mechanisms of SARS-CoV-2 Human furin is a calcium-177 dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently 178 cleaves anthrax toxin protective antigen Purification 180 and characterization of furin, a Kex2-like processing endoprotease, produced in Chinese 181 hamster ovary cells An acidic sequence within the cytoplasmic 183 domain of furin functions as a determinant of trans-Golgi network localization and 184 internalization from the cell surface Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing 186 of a wide variety of precursor proteins Furin-mediated protein processing in infectious diseases and cancer Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage 190 to Suppress Virus Production and Cytopathic Effects Furin: A Potential Therapeutic Target for COVID-19. iScience A review of the phytochemistry and pharmacological activities of 194 Magnoliae officinalis cortex Neuroprotective effects of neolignans isolated 196 from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells Antimicrobial effect of Magnolia officinalis extract against 199 Staphylococcus aureus Magnolia officinalis L. bark extract as the most potent anti-inflammatory of four plant extracts Inhibitory effect of Daesungki-Tang on the invasiveness 204 potential of hepatocellular carcinoma through inhibition of matrix metalloproteinase-2 and -9 205 activities Magnolol and honokiol from Magnolia officinalis 207 enhanced antiviral immune responses against grass carp reovirus in Ctenopharyngodon idella 208 kidney cells Inhibition of Herpes Simplex Virus-1 Replication by Natural 212 Screening for inhibitory 214 effects of crude drugs on furin-like enzymatic activities Enhanced isolation of SARS-CoV-2 by TMPRSS2-216 expressing cells Honokiol induces autophagy of 218 neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular 219 stress/ERK1/2 signaling pathways and suppressing cell migration Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR 222 signaling modulation for Middle East respiratory syndrome coronavirus infection as identified 223 by temporal kinome analysis Blocking the PI3K/AKT pathway enhances mammalian reovirus 225 replication by repressing IFN-stimulated genes SARS-CoV-2 infects cells after viral entry via 227 clathrin-mediated endocytosis